Immunotherapy Combinations for Lung Cancers: Challenges and Opportunities of Rapidly Evolving Treatments

Few oncology treatment paradigms are evolving as rapidly as those for lung cancer. In particular emerging data and indications for immunotherapy combinations in both NSCLC and SCLC have resulted in an explosion of new therapeutic options. Review the program Webcast and download the slidesets to deepen your understanding of current and evolving best practices!  This is not an official program of the American Association for Cancer Research Annual Meeting.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Genentech TEXT Only